Market Outlook
The U.S. Post-Surgical Rehabilitation Devices Market stood at USD 4.82 billion in 2026 and is projected to reach approximately USD 8.34 billion by 2032, expanding at a CAGR of 9.57% during 2027–2032. Historical market value increased from USD 3.75 billion in 2023 to USD 4.06 billion in 2024 and USD 4.43 billion in 2025, reflecting sustained growth in surgical procedure volumes, faster discharge pathways, rising rehabilitation intensity after orthopedic and spine surgery, and increasing use of connected recovery technologies.
The forecast trajectory places the market at approximately USD 5.28 billion in 2027, USD 5.79 billion in 2028, USD 6.34 billion in 2029, USD 6.95 billion in 2030, USD 7.61 billion in 2031, and USD 8.34 billion in 2032. Values in this report are expressed in USD billions unless otherwise stated.
The market comprises devices used after surgery to restore mobility and function, improve range of motion, manage pain and swelling, provide joint or musculoskeletal support, prevent deconditioning, facilitate therapeutic exercise, and enable clinicians to monitor recovery outside the hospital. The scope includes mobility and assistive devices, braces and orthoses, continuous passive motion systems, electrotherapy devices, neuromuscular electrical stimulation systems, cold and compression therapy platforms, connected rehabilitation equipment, sensor-enabled recovery devices, and selected robotic or automated rehabilitation systems. Implantable surgical devices, pharmaceuticals, standalone wound-care consumables, and revenue generated purely from physical or occupational therapy services are outside the core market definition.
Demand is becoming increasingly tied to the economics of the entire surgical episode rather than the hospital procedure alone. U.S. health systems are being measured on complications, functional recovery, readmissions, discharge disposition, patient-reported outcomes, and post-acute spending. Consequently, a rehabilitation device that helps move a patient safely from the hospital to home, reduces dependence on institutional post-acute care, supports adherence to prescribed exercises, or allows clinicians to detect delayed recovery earlier can create economic value extending well beyond its purchase price.
Orthopedic surgery remains the principal revenue engine, particularly total knee arthroplasty, total hip arthroplasty, fracture repair, shoulder reconstruction, ligament repair, and spine surgery. However, demand is broadening into cardiothoracic, abdominal, neurological, and other major surgical pathways where early mobilization, pulmonary conditioning, muscle preservation, gait restoration, and home-based functional monitoring are increasingly incorporated into standardized recovery programs.
The U.S. demographic structure reinforces this opportunity. More than 61 million Americans were aged 65 years or older in 2024, creating a large population with comparatively high exposure to joint replacement, spine surgery, fracture repair, cardiac surgery, and other procedures requiring structured recovery. Simultaneously, post-surgical rehabilitation is moving away from long institutional stays and toward shorter hospital episodes, outpatient therapy, ambulatory surgery, and technology-supported home rehabilitation.
Introduction
The U.S. Post-Surgical Rehabilitation Devices Market occupies a strategically important position between the operating room and long-term functional recovery. A successful surgical procedure does not automatically produce a successful patient outcome. Following joint replacement, spine fusion, ligament reconstruction, fracture fixation, cardiac surgery, or other major operations, the patient must regain strength, mobility, range of motion, balance, endurance, and the ability to perform activities of daily living. Rehabilitation devices provide the physical and increasingly digital infrastructure required to achieve those objectives.
The addressable clinical population is substantial. The American Joint Replacement Registry has accumulated more than 4 million hip and knee arthroplasty procedures and continues to expand across hospitals, ambulatory surgery centers, and physician groups nationwide. The American Spine Registry has similarly built a dataset covering hundreds of thousands of lumbar and cervical procedures. These registry volumes demonstrate the depth of the orthopedic procedure base feeding demand for postoperative braces, walking aids, cold-compression systems, CPM devices, therapeutic stimulation, home exercise systems, and digital recovery platforms.
The market also operates within one of the world’s largest healthcare delivery systems. U.S. hospitals collectively maintain more than 900,000 staffed beds and record more than 35 million annual admissions. At the same time, outpatient surgery is expanding rapidly. Approximately 6,400 ambulatory surgical centers treated about 3.4 million Medicare fee-for-service beneficiaries in 2024 alone. Orthopedic procedures are increasingly migrating into this lower-cost setting, creating a different rehabilitation purchasing model in which compact equipment, rapid patient education, home-use devices, rental programs, and remote recovery technologies become more important than hospital-based capital equipment alone.
Post-acute infrastructure is equally significant. Medicare data show a national ecosystem of thousands of skilled nursing facilities, home health agencies, and inpatient rehabilitation facilities caring for millions of beneficiaries. This environment creates multiple device purchasing points after surgery, but it also creates pressure to identify lower-cost alternatives to facility-based rehabilitation where clinically appropriate.
The market is therefore evolving from a collection of basic rehabilitation products into an integrated recovery ecosystem. Traditional walkers, braces, compression devices, CPM systems, and electrical stimulators remain clinically relevant, but growth is increasingly associated with devices capable of documenting utilization, transmitting functional data, guiding exercise progression, measuring range of motion, assessing gait or activity, and connecting patients with clinical teams.
A second structural change is the transition from device procurement based primarily on unit cost toward procurement based on episode economics. Hospitals, surgeons, payers, physical therapy groups, and post-acute providers increasingly ask whether a device can accelerate ambulation, support same-day or next-day discharge, reduce therapy labor requirements, decrease emergency department utilization, prevent avoidable readmission, or improve patient-reported functional recovery.
This makes post-surgical rehabilitation a particularly attractive area for manufacturers capable of combining medical hardware with patient engagement, data analytics, clinical protocols, reimbursement support, and real-world evidence.
Key Market Drivers: What Is Fueling the U.S. Post-Surgical Rehabilitation Devices Market?
A primary growth driver is the scale of musculoskeletal surgery in the United States. Joint replacement and spine procedures produce substantial rehabilitation requirements because recovery depends on restoring movement, strength, balance, and confidence after surgical intervention. Current U.S. orthopedic registries contain millions of joint replacement cases and hundreds of thousands of spine procedures, illustrating the recurring procedure base available to rehabilitation device manufacturers.
A second driver is population aging. The U.S. population aged 65 years and older exceeded 61 million in 2024. Older adults have greater exposure to osteoarthritis, degenerative spine disease, fragility fractures, cardiovascular disease, and other conditions that can lead to surgery. They are also more likely to require walking assistance, fall-risk management, strengthening, range-of-motion support, and post-discharge monitoring. This creates durable demand for both conventional rehabilitation hardware and newer connected recovery devices.
A third driver is the continued movement of surgery into outpatient settings. Approximately 6,400 Medicare-certified ambulatory surgical centers were operating nationally in 2024, and ASC procedure volume continues to increase. Total joint replacement and selected spine and orthopedic procedures that historically required multi-day hospitalization can increasingly be performed with shorter lengths of stay in carefully selected patients. Rehabilitation therefore begins earlier and transfers more quickly to the home. Manufacturers that design portable, intuitive, patient-operated equipment are well positioned for this shift.
A fourth driver is the economic migration of post-acute care toward the home. Medicare’s post-acute infrastructure included roughly 12,220 home health agencies serving 2.6 million fee-for-service users in 2024, compared with approximately 14,500 skilled nursing facilities serving 1.1 million users and around 1,170 inpatient rehabilitation facilities serving 377,000 users. The economic differences between these settings encourage health systems and payers to identify patients who can recover safely at home with appropriate equipment and clinical oversight.
A fifth driver is bundled and episode-based reimbursement. U.S. reimbursement policy is increasingly designed around accountability extending beyond the surgical procedure. Hospitals participating in episode-based models have greater financial reasons to manage discharge destination, physical therapy utilization, readmissions, complications, and recovery efficiency. This makes rehabilitation technology relevant to hospital finance teams rather than only physical therapists.
The Transforming Episode Accountability Model is particularly important because it incorporates lower-extremity joint replacement, hip/femur fracture surgery, spinal fusion, coronary artery bypass grafting, and major bowel surgery into episodes extending through the first 30 days after hospital discharge. These categories represent substantial potential demand for mobility aids, strengthening systems, compression technologies, monitoring devices, and home-based rehabilitation platforms.
A sixth driver is greater emphasis on functional outcomes. CMS quality programs increasingly incorporate patient-reported outcomes after total hip and knee replacement. Providers therefore have a stronger incentive to monitor whether patients actually regain mobility, experience meaningful pain reduction, and return to functional independence. Connected rehabilitation devices that create measurable longitudinal datasets can become strategically valuable under these conditions.
The physical therapy workforce also supports market expansion while simultaneously creating a need for workflow efficiency. The United States employed more than 267,000 physical therapists in 2025, alongside a large base of physical therapist assistants and occupational therapists. Yet demand for rehabilitation professionals continues to rise. Devices that allow one clinician to supervise a larger patient population, standardize exercise progression, or remotely identify patients requiring intervention can partially address capacity pressure.
Finally, consumer expectations are changing. Patients increasingly expect hospital-grade recovery support without prolonged hospitalization. Smartphone-based care plans, wearable sensors, connected range-of-motion measurement, app-guided exercise, virtual coaching, adherence tracking, and home-delivered equipment are becoming more compatible with the broader consumerization of healthcare. The strongest solutions do not replace physical therapists; they extend therapeutic oversight between visits.
Innovation in Focus: How Manufacturers Are Raising the Bar?
Innovation in post-surgical rehabilitation is shifting from isolated mechanical products toward intelligent recovery platforms. The competitive question is increasingly not whether a manufacturer can provide a brace, stimulator, walker, compression system, or exercise device, but whether the company can connect that product to a measurable postoperative recovery pathway.
Connected range-of-motion measurement is becoming particularly important after knee, hip, shoulder, and spine procedures. Historically, clinicians depended heavily on scheduled clinic or therapy visits to assess progress. Sensor-enabled systems can now provide objective information on motion, activity, exercise completion, and functional milestones from the patient’s home. This allows clinical teams to identify recovery trajectories that are falling behind expected benchmarks.
Cold and compression therapy is also becoming more sophisticated. Traditional ice therapy remains widespread because pain and swelling are major barriers to early mobilization. Newer systems combine controlled cooling with active or intermittent compression, standardized temperature management, and portable designs suitable for home use. The clinical value proposition is strongest when the system contributes to pain management while reducing reliance on more resource-intensive interventions.
Neuromuscular electrical stimulation is gaining attention for preserving or restoring muscle activation after procedures associated with rapid quadriceps inhibition or general deconditioning. Knee surgery is a particularly relevant use case because substantial quadriceps weakness may occur early after surgery. Electrical stimulation platforms are increasingly designed for straightforward patient operation and integration into home exercise protocols.
Rehabilitation robotics and automated exercise systems are moving gradually beyond neurological rehabilitation into orthopedic and post-surgical recovery. The most commercially relevant technologies will be those that achieve clinical value without creating excessive capital cost, staffing complexity, or infrastructure requirements. Compact systems that automate repetitive motion, resistance progression, gait practice, or functional exercise may gain greater adoption than large fixed robotic systems.
Another significant innovation area is remote therapeutic monitoring. Connected rehabilitation devices can support collection of musculoskeletal status, adherence, therapy activity, and other clinically relevant information between conventional visits. This creates an opportunity to redesign the economics of rehabilitation around continuous oversight rather than intermittent encounters.
Artificial intelligence is beginning to enter the market through recovery-risk stratification, movement assessment, computer-vision exercise monitoring, automated progression recommendations, and identification of patients who may require escalation. The highest-value AI applications will be those embedded within validated clinical pathways rather than generic consumer wellness applications.
Segmentation Insights
The U.S. Post-Surgical Rehabilitation Devices Market is segmented by product type, surgery type, rehabilitation phase, technology, end user, and geography.
- By Product Type
Mobility and Assistive Devices
Mobility and assistive devices represented approximately USD 1.28 billion in 2026, making this the largest individual product category. Walkers, crutches, canes, rollators, transfer aids, raised seating solutions, and related mobility equipment remain fundamental after total joint replacement, fracture repair, lower-extremity surgery, spine procedures, and major operations affecting strength or balance.
The segment is supported by the industry’s move toward earlier ambulation. Modern enhanced-recovery protocols often encourage patients to stand and walk within hours of surgery when clinically appropriate. That increases the importance of safe, adjustable, lightweight equipment capable of supporting discharge directly to home.
Cold and Compression Therapy Devices
Cold and compression systems accounted for approximately USD 0.94 billion in 2026. Demand is strongest following knee replacement, ACL reconstruction, shoulder surgery, hip procedures, sports orthopedic surgery, and other operations associated with significant postoperative swelling.
The category is moving toward integrated cold-compression systems rather than passive ice packs alone. Controlled therapy delivery, portable power, simplified patient interfaces, and rental or home-delivery models support premiumization. The segment is expected to grow above the market average as multimodal pain management becomes more important in opioid-reduction strategies.
Braces, Orthoses and Postoperative Supports
Postoperative braces and orthotic supports generated approximately USD 0.83 billion in 2026. Products include knee braces, spinal orthoses, shoulder immobilizers, hip supports, ankle-foot orthoses, postoperative shoes, cervical supports, and customizable stabilization systems.
The addressable patient pool is supported by substantial orthopedic and spine procedural activity. The American Spine Registry alone reached a cumulative volume exceeding 466,000 lumbar and cervical procedures through 2024, while U.S. joint replacement registries encompass millions of hip and knee procedures. These procedures frequently require defined restrictions or mechanical support during specific stages of recovery.
Electrotherapy and Neuromuscular Stimulation Devices
Electrotherapy and neuromuscular stimulation devices represented approximately USD 0.68 billion in 2026. The segment includes TENS devices, NMES platforms, electrical muscle stimulation systems, and selected therapeutic stimulation technologies used for pain modulation or muscle activation.
Growth is strongest in orthopedic recovery because muscle inhibition can delay functional progression after surgery. Home-capable NMES systems are particularly attractive when integrated with structured rehabilitation programs rather than sold as standalone pain-control products.
Continuous Passive Motion Devices
Continuous passive motion systems accounted for approximately USD 0.46 billion in 2026. CPM remains a clinically selective segment, with utilization varying significantly by surgical procedure, surgeon preference, payer policy, and rehabilitation protocol.
Knee and shoulder procedures represent important applications. While CPM is more mature than connected rehabilitation technologies, the category retains recurring demand through hospitals, equipment rental companies, rehabilitation providers, and home-care channels. Product innovation is centered on portability, quieter operation, easier fitting, digital controls, and home logistics.
Digital and Connected Rehabilitation Devices
Digital and connected rehabilitation hardware generated approximately USD 0.63 billion in 2026 and is expected to be the fastest-growing product segment through 2032. The category includes connected exercise devices, motion sensors, smart therapeutic equipment, wearable recovery monitors, remote range-of-motion systems, and device-linked rehabilitation platforms.
Growth is being accelerated by patient-reported outcome requirements, bundled surgical episodes, outpatient migration, and the rising importance of recovery adherence. Connected devices create data that can be reviewed by therapists, surgeons, and care-management teams rather than depending entirely on patient recall.
- By Surgery Type
Orthopedic Joint Replacement Surgery
Joint replacement represented approximately USD 2.05 billion in 2026, accounting for more than two-fifths of total market demand. Hip and knee arthroplasty create broad requirements across mobility aids, compression, braces, strength recovery, motion restoration, home exercise equipment, and digital outcome monitoring.
The American Joint Replacement Registry’s multi-million-procedure dataset demonstrates the scale of the underlying clinical population. Joint replacement is also particularly exposed to episode-based reimbursement, making recovery efficiency and discharge destination commercially relevant to health systems.
Spine Surgery
Spine procedures contributed approximately USD 0.93 billion in 2026. Cervical fusion, lumbar fusion, decompression, and other spine surgeries can produce substantial requirements for braces, walking support, strength restoration, home exercise, posture management, and functional monitoring.
The American Spine Registry reached approximately 466,000 cumulative procedures through 2024. Lumbar spinal stenosis is a major diagnosis represented in the registry, while fusion and decompression procedures account for substantial procedural volume. Recovery pathways can range from rapid discharge for lower-complexity procedures to extended rehabilitation following complex fusion.
Sports Medicine and Soft-Tissue Surgery
Sports medicine and soft-tissue procedures represented approximately USD 0.64 billion in 2026. ACL reconstruction, rotator cuff repair, meniscal surgery, tendon repair, cartilage procedures, and other arthroscopic interventions frequently require progressive range-of-motion and strengthening protocols.
This subsegment produces strong demand for postoperative bracing, cold-compression systems, NMES devices, resistance equipment, and app-supported rehabilitation because the recovery objective frequently extends beyond basic activities of daily living to restoration of higher-level movement and performance.
Cardiothoracic Surgery
Cardiothoracic postoperative rehabilitation represented approximately USD 0.48 billion in 2026. Demand includes mobility equipment, respiratory-conditioning support, functional strengthening, walking aids, activity monitoring, and selected connected recovery technologies.
The Society of Thoracic Surgeons National Database contains data from millions of cardiothoracic procedures and captures the overwhelming majority of U.S. adult cardiac surgery activity. As cardiac surgery pathways emphasize earlier mobilization and structured recovery after discharge, rehabilitation technology has become increasingly relevant.
Neurological, Trauma and Other Major Surgery
Neurological, trauma, abdominal, oncology-related, and other major surgical procedures collectively represented approximately USD 0.72 billion in 2026. Demand varies substantially by functional impairment, but mobility assistance, transfer equipment, muscle stimulation, strengthening, and home recovery support are recurring requirements.
This category has significant upside where devices can be shared across multiple surgical populations rather than being restricted to a single specialty.
- By Rehabilitation Phase
Acute and In-Hospital Rehabilitation
Acute and hospital-based rehabilitation accounted for approximately USD 1.39 billion in 2026. Hospitals remain essential users of walkers, transfer devices, braces, early-mobility equipment, electrical stimulation, compression systems, and selected rehabilitation capital equipment.
The U.S. hospital system includes approximately 6,100 hospitals, more than 907,000 staffed beds, and roughly 35.7 million annual admissions, creating a substantial clinical infrastructure for early postoperative mobilization.
The strategic objective in this segment is increasingly rapid functional readiness for discharge. Hospitals value devices that are simple to deploy, require limited staff training, can be standardized across service lines, and facilitate transition to the next care setting.
Outpatient Rehabilitation
Outpatient rehabilitation generated approximately USD 1.48 billion in 2026. Physical therapy practices, hospital outpatient departments, orthopedic clinics, sports medicine centers, and comprehensive rehabilitation facilities are major users.
More than 267,000 physical therapists were employed nationally in 2025, supplemented by physical therapist assistants, occupational therapists, and other rehabilitation professionals. Outpatient clinics therefore represent a substantial recurring purchasing base for therapeutic exercise equipment, electrical stimulation, motion devices, balance equipment, and connected rehabilitation technologies.
Home-Based Rehabilitation
Home rehabilitation was the largest phase-based segment at approximately USD 1.95 billion in 2026 and is expected to gain additional share through 2032.
The home has become an increasingly important postoperative recovery environment as length of stay falls and more surgical procedures move outpatient. Medicare data show approximately 12,220 home health agencies serving around 2.6 million fee-for-service users during 2024. Although not all are surgical patients, this infrastructure demonstrates the scale at which skilled care is already delivered in the home.
Portable, easily configured devices have a major advantage in this segment. Connected rehabilitation equipment, compact cold-compression systems, electrical stimulation devices, mobility aids, and sensor-enabled exercise platforms can support continuity after patients leave direct supervision.
- By Technology
Conventional Mechanical Rehabilitation
Mechanical devices represented approximately USD 2.38 billion in 2026 and remain the largest technology category. The segment encompasses walking aids, manual exercise systems, braces, orthotic supports, CPM equipment, transfer devices, and non-connected therapeutic products.
These products benefit from established clinical workflows, relatively straightforward reimbursement, broad distribution, and familiarity among therapists and surgeons. Competition is therefore based heavily on durability, ergonomics, adjustability, logistics, contracting, and total lifecycle cost.
Electrotherapeutic Technologies
Electrotherapeutic technologies represented approximately USD 1.14 billion in 2026 when pain-management stimulation, muscle stimulation, and related electrically powered therapeutic products are considered across postoperative applications.
Growth is increasingly concentrated in devices with stronger clinical positioning, simple home operation, integrated protocols, and measurable utilization rather than undifferentiated consumer stimulation products.
Sensor-Enabled and Connected Technologies
Sensor-enabled systems accounted for approximately USD 0.85 billion in 2026 and represent one of the highest-growth technology areas. Motion sensors, wearable devices, connected therapeutic hardware, activity trackers, and digitally instrumented exercise systems enable clinicians to observe recovery remotely.
The business value extends beyond hardware revenue. Data generated during rehabilitation may support patient engagement, outcomes documentation, risk stratification, and more efficient allocation of clinical labor.
Automated and Robotic Rehabilitation Technologies
Automated and robotic rehabilitation technologies represented approximately USD 0.45 billion in 2026. Adoption remains concentrated in higher-acuity rehabilitation facilities, advanced orthopedic programs, and selected home recovery platforms.
The category is expected to expand as systems become smaller, less expensive, and more compatible with routine postoperative care. The strongest commercial opportunities are likely to emerge from devices that automate high-frequency repetitive exercise without eliminating clinician oversight.
- By End User
Hospitals and Integrated Health Systems
Hospitals represented approximately USD 1.41 billion in 2026. Their purchasing influence extends beyond devices physically used during hospitalization because large integrated systems increasingly coordinate surgical recovery across outpatient therapy, home health, and digital care programs.
Enterprise procurement is becoming more sophisticated. Value-analysis committees evaluate clinical evidence, staff workflow, standardization potential, reimbursement exposure, supply reliability, cybersecurity for connected products, and impact on total episode economics.
Ambulatory Surgical Centers
ASCs represented approximately USD 0.61 billion in 2026 and are among the fastest-growing end-user segments.
Around 6,400 ASCs treated approximately 3.4 million fee-for-service Medicare beneficiaries in 2024. As appropriate orthopedic procedures move to ASCs, postoperative devices increasingly need to be prescribed, fitted, educated, and transferred to the patient within a short encounter. This favors compact devices and strong home-distribution capabilities.
Outpatient Rehabilitation and Physical Therapy Centers
Outpatient rehabilitation providers represented approximately USD 1.22 billion in 2026. They are particularly important for therapeutic exercise equipment, electrotherapy, motion restoration, strength systems, balance technologies, and connected rehabilitation.
The segment remains fragmented relative to hospital procurement, making distribution networks, clinician education, equipment financing, reliability, and customer service important competitive differentiators.
Home Healthcare and Direct-to-Patient Recovery
Home healthcare and direct patient use represented approximately USD 1.10 billion in 2026. This category is growing rapidly because the point of recovery is moving away from institutions.
Successful manufacturers increasingly require logistics capabilities in addition to product capabilities. Home delivery, fitting instructions, virtual support, patient onboarding, cleaning and refurbishment for rental equipment, device return management, and remote technical support can materially influence purchasing decisions.
Inpatient Rehabilitation Facilities and Skilled Nursing Facilities
IRFs and SNFs accounted for approximately USD 0.48 billion in 2026. In 2024, fee-for-service Medicare served roughly 377,000 IRF users and approximately 1.1 million SNF users.
These settings manage patients with greater functional impairment than typical outpatient or home populations and therefore require durable mobility, transfer, strengthening, balance, gait, electrical stimulation, and higher-intensity rehabilitation equipment.
Regional Insights: Where Is the U.S. Market Growing Fastest?
The U.S. Post-Surgical Rehabilitation Devices Market is geographically divided into the South, West, Northeast, and Midwest. Regional demand differs according to population scale, age profile, surgical procedure intensity, hospital and ASC capacity, orthopedic specialist density, rehabilitation infrastructure, payer mix, population migration, and adoption of home-based recovery.
In 2026, the South represented approximately USD 1.77 billion, the West USD 1.13 billion, the Northeast USD 1.10 billion, and the Midwest USD 0.82 billion. The South is the largest regional market, while the West is positioned to deliver the fastest expansion through 2032.
South
The South accounts for approximately 36.7% of the national market, making it the largest U.S. region for post-surgical rehabilitation devices. The regional market is projected to expand from USD 1.77 billion in 2026 to approximately USD 3.15 billion by 2032, representing growth above the national average.
The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, West Virginia, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma and the District of Columbia.
Texas is the most commercially important Southern state, with 2026 demand of approximately USD 0.40 billion. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major orthopedic, spine, trauma, rehabilitation, and integrated delivery networks. Rapid population growth is expanding the pool of commercially insured surgical patients, while a large Medicare population supports joint replacement and spine rehabilitation. The state’s extensive ASC ecosystem also creates attractive opportunities for home-based recovery equipment.
Florida represented approximately USD 0.33 billion in 2026. The state’s unusually large older population makes it especially relevant to hip and knee replacement, spine surgery, fracture recovery, and cardiac rehabilitation. Florida is also well suited to direct-to-home and home-health rehabilitation because of its large retiree communities and high concentration of Medicare beneficiaries.
North Carolina generated approximately USD 0.13 billion, supported by major academic and integrated health systems, growing metropolitan populations, orthopedic specialty groups, and expanding outpatient surgical infrastructure. Georgia represented approximately USD 0.12 billion, while Virginia generated approximately USD 0.11 billion.
Tennessee has strategic relevance beyond its population size because Nashville is a major U.S. healthcare services and hospital-management center. Maryland and Virginia benefit from dense health-system infrastructure in the Baltimore-Washington corridor, while the Carolinas and Georgia are benefiting from strong demographic growth.
Alabama, Mississippi, Arkansas, Louisiana, Kentucky and West Virginia represent smaller device markets but have meaningful orthopedic, cardiovascular, obesity-related, and mobility-related disease burdens. Rural accessibility challenges can increase the value of rehabilitation models that minimize repeated travel to specialty centers.
The South is particularly attractive for manufacturers of mobility devices, bracing, home cold-compression systems, electrical stimulation, and remote recovery platforms. Population migration and healthcare construction should keep the region in the national leadership position throughout the forecast period.
West
The West represented approximately USD 1.13 billion in 2026, equivalent to roughly 23.4% of the national market, and is forecast to reach approximately USD 2.20 billion by 2032. This implies the fastest regional CAGR among the four major U.S. regions.
The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, Idaho, Montana, Wyoming, New Mexico, Alaska and Hawaii.
California is the largest Western state market at approximately USD 0.46 billion in 2026. The state combines a population approaching 40 million, more than 6.5 million residents aged 65 or older, major academic medical institutions, large orthopedic networks, and one of the country’s strongest digital-health ecosystems.
California is particularly important for sensor-enabled rehabilitation, remote monitoring, AI-supported musculoskeletal recovery, and digitally integrated therapy. Health systems in Los Angeles, San Diego, the Bay Area, Sacramento and other major markets frequently serve as early adopters of technologies that can demonstrate clinical and economic differentiation.
Arizona represented approximately USD 0.12 billion in 2026 and is one of the region’s most compelling growth markets. Population migration and a substantial retirement population create strong demand for joint replacement, mobility restoration, and spine recovery.
Washington represented approximately USD 0.10 billion, while Colorado accounted for approximately USD 0.09 billion. Both states have sophisticated health systems and relatively strong adoption of connected care models. Oregon and Nevada each provide attractive opportunities for outpatient and home rehabilitation, while Utah combines strong population growth with advanced integrated provider systems.
The Western market is strategically different from the South. Its growth is not driven solely by procedure volume. The region has a disproportionate influence on technology adoption, software integration, digital patient engagement, remote monitoring, and venture-backed rehabilitation innovation.
This makes the West particularly favorable for manufacturers offering connected devices, sensor-enabled equipment, smart therapeutic systems, and technology platforms that can integrate with health-system digital infrastructure.
Northeast
The Northeast represented approximately USD 1.10 billion in 2026, or roughly 22.8% of the national market, and is projected to reach approximately USD 1.75 billion by 2032.
The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, New Hampshire, Rhode Island and Vermont.
New York is the largest Northeast state market, contributing approximately USD 0.25 billion in 2026. The state has a high concentration of large academic medical centers, integrated hospital networks, orthopedic specialty centers, rehabilitation hospitals, and outpatient therapy infrastructure. High surgical complexity supports premium rehabilitation equipment, although procurement is frequently formalized through health-system value-analysis processes.
Pennsylvania represented approximately USD 0.17 billion, supported by substantial healthcare infrastructure in Philadelphia, Pittsburgh and surrounding markets. New Jersey contributed approximately USD 0.15 billion and benefits from high population density, strong commercial insurance penetration, proximity to major metropolitan referral centers, and a substantial orthopedic surgery base.
Massachusetts represented approximately USD 0.13 billion. Boston’s academic ecosystem makes the state disproportionately influential in clinical research, evidence generation, new technology evaluation, and specialist training. Connecticut is another high-value market, particularly for orthopedic and spine rehabilitation.
Maine, New Hampshire, Rhode Island and Vermont are smaller in absolute value but have older demographic profiles in several communities. These states can benefit from home-based devices that reduce the need for repeated travel to centralized specialty hospitals.
Growth in the Northeast will be slower than in the South or West because population expansion is comparatively modest and the healthcare infrastructure is mature. However, average technology intensity is high. Providers are more likely to evaluate premium rehabilitation technologies when clinical evidence demonstrates improvements in functional outcomes, discharge efficiency, or labor productivity.
The region is particularly relevant for connected rehabilitation systems, high-quality bracing, advanced compression devices, clinical-grade NMES, and rehabilitation technologies linked to academic or specialty surgical programs.
Midwest
The Midwest accounted for approximately USD 0.82 billion in 2026, representing roughly 17.0% of the U.S. market, and is forecast to reach approximately USD 1.24 billion by 2032.
The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota and South Dakota.
Illinois is the largest Midwest state market at approximately USD 0.15 billion, led by Chicago’s extensive academic, community hospital, orthopedic, and rehabilitation infrastructure.
Ohio contributed approximately USD 0.13 billion, supported by major health systems and a strong base of orthopedic, spine, cardiovascular and rehabilitation programs. Michigan represented approximately USD 0.11 billion, while Minnesota generated approximately USD 0.09 billion.
Minnesota is strategically influential because of its long-standing medical-device ecosystem. It is well positioned for clinical partnerships and new product development even though its absolute population is lower than Illinois or Ohio.
Indiana, Wisconsin and Missouri provide stable demand across orthopedic surgery, rehabilitation clinics, and hospital-based care. Iowa, Kansas, Nebraska, North Dakota and South Dakota are smaller markets but present an important use case for home rehabilitation and remote patient management because patients may travel significant distances for specialist surgical care.
The Midwest will expand more steadily than aggressively. Buyers tend to place significant value on device durability, clinical utility, contract economics, local support, and supply reliability. Manufacturers capable of pairing technology with strong distribution and service infrastructure should outperform purely technology-led competitors.
Key Market Players
The U.S. Post-Surgical Rehabilitation Devices Market is fragmented across mobility equipment, orthopedic bracing, electrotherapy, cold-compression systems, rehabilitation equipment, connected recovery platforms, and home-based rehabilitation technology. Competition is moving toward broader recovery ecosystems rather than standalone products.
The following are approximately 15 of the most relevant companies active in the U.S. competitive landscape:
Enovis Corporation
Breg, Inc.
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Össur Americas
Avanos Medical, Inc.
Medline Industries, LP
Cardinal Health, Inc.
Performance Health
Drive DeVilbiss Healthcare
Zynex, Inc.
Dynatronics Corporation
Kinex Medical Company
ROMTech
BioMedical Life Systems, Inc.
Enovis and Breg have particularly strong relevance in orthopedic bracing, cold therapy, postoperative supports, and rehabilitation products. Zimmer Biomet and Stryker benefit from close relationships with orthopedic surgeons and health systems, creating opportunities to connect postoperative recovery with surgical pathways.
Avanos participates in premium cold and compression therapy through the Game Ready platform, while Zynex is strongly positioned in electrotherapy and pain-management technologies. Medline, Cardinal Health, Performance Health, and Drive DeVilbiss benefit from extensive distribution capabilities and broad access to hospitals, rehabilitation centers, home healthcare, and durable medical equipment channels.
Kinex Medical has a direct role in home rehabilitation and postoperative equipment, while ROMTech represents the emerging connected-recovery model in which therapeutic hardware, patient engagement, and remote clinical oversight are integrated.
Competitive advantage through 2032 will increasingly depend on clinical evidence, reimbursement support, home logistics, digital integration, ability to document outcomes, contracting flexibility, and capacity to work across the full surgical episode.
Recent Developments
A defining development in 2026 is the implementation of the Transforming Episode Accountability Model, which places selected acute-care hospitals under episode accountability for five major surgical categories: lower-extremity joint replacement, surgical hip/femur fracture treatment, spinal fusion, coronary artery bypass grafting, and major bowel procedures.
The model’s relevance to rehabilitation device manufacturers is substantial because the episode extends through 30 days after the patient leaves the hospital. Hospitals therefore have stronger incentives to manage the transition from surgery to functional recovery rather than viewing rehabilitation as an economically separate event.
A second major development is the announced expansion of Medicare’s joint-replacement episode strategy through CJR-X, scheduled to begin nationally in 2028. Hospitals will be accountable for the joint-replacement episode and the initial 90 days of recovery. This expands the strategic importance of home physical therapy, remote monitoring, mobility support, adherence technology, and other interventions that can reduce avoidable utilization while preserving outcomes.
A third development is the growing formalization of patient-reported outcome measurement after total hip and knee replacement. Functional recovery and pain improvement are increasingly becoming measurable quality variables. Device manufacturers capable of collecting objective movement or adherence data can therefore position their products within a broader outcome-management strategy.
A fourth development is the continued migration of procedures to ambulatory surgery centers. Approximately 6,400 ASCs treated 3.4 million Medicare fee-for-service beneficiaries in 2024, and sector capacity continues to expand. As appropriate orthopedic surgery shifts away from inpatient hospitals, the rehabilitation supply chain is changing from centralized hospital purchasing to a combination of ASC prescribing, home delivery, outpatient therapy, and remote follow-up.
A fifth development is the expansion of connected postoperative care. Manufacturers are developing devices that allow recovery to be measured rather than inferred. Range of motion, activity, exercise completion, muscle engagement, gait patterns, pain reporting, and functional milestones can increasingly be collected outside the clinic. This creates a new competitive layer in which data infrastructure is nearly as important as physical device design.
A sixth development is healthcare labor pressure. Rehabilitation providers face rising patient demand while physical therapist availability remains constrained in many local markets. Technology that automates routine exercise, provides asynchronous oversight, or identifies patients who require direct clinician attention can increase therapist productivity without attempting to remove the clinician from the care pathway.
Conclusion
The U.S. Post-Surgical Rehabilitation Devices Market is positioned to expand from USD 4.82 billion in 2026 to USD 8.34 billion by 2032 at a CAGR of 9.57%. Growth is being driven by a combination of rising surgical volume, population aging, outpatient procedure migration, shorter hospital stays, expansion of home recovery, episode-based reimbursement, patient-reported outcome requirements, and connected rehabilitation technology.
The strongest commercial opportunity remains orthopedic recovery, particularly hip and knee replacement, spine surgery, sports medicine, fracture repair, and other procedures requiring rapid restoration of mobility. However, cardiothoracic and other major surgical pathways provide additional growth potential as early mobilization and structured post-discharge recovery become increasingly standardized.
Product-market attractiveness is also changing. Conventional walking aids, braces, cold therapy, compression systems, CPM equipment, and electrical stimulation will remain important, but premium growth will increasingly come from products that combine physical therapy functionality with measurable recovery data.
Home-based rehabilitation is expected to capture a growing share of value because surgical recovery is moving rapidly beyond the hospital. Manufacturers will therefore require capabilities in patient onboarding, delivery logistics, remote technical support, adherence monitoring, device connectivity, and clinician workflow integration.
Regional opportunity will remain strongest in the South, driven by population scale, demographic migration, surgical demand, and expansion of outpatient infrastructure. The West is expected to produce the fastest growth because of its combination of demographic expansion and early adoption of connected healthcare technologies. The Northeast will remain a high-value market for advanced, evidence-driven rehabilitation products, while the Midwest will provide durable demand supported by established health systems and rehabilitation networks.
For manufacturers, investors, distributors, hospitals, and strategic buyers evaluating this market, the central commercial question is no longer simply how many patients require rehabilitation after surgery. The more important issue is which devices can measurably accelerate functional recovery while reducing the resources required across the surgical episode.
Companies capable of demonstrating improved mobility, stronger adherence, lower downstream utilization, more efficient clinical workflows, successful home recovery, and credible real-world outcomes will be best positioned to capture premium growth through 2032.